Investor Relations
GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
Annual Reports
Recent Releases
May 8, 2012
GenMark Diagnostics Reports First Quarter 2012 Results
Apr 27, 2012
GenMark Diagnostics Schedules First Quarter 2012 Financial Results and Conference Call for May 8, 2012
Events
May 8, 2012 at 4:30 PM ET
GenMark Diagnostics First Quarter Earnings Conference Call
Related Links
Stock Quote
Price:
4.54
Change:
- 0.04
Day High:
4.65
Day Low:
4.50
Volume:
19,300
NASDAQ
GNMK
3:52 PM ET on May 18, 2012
Delayed at least 20 minutes.
Provided by eSignal.
Provided by eSignal.